ACELYRIN, Inc. SEC Filings

Filed On	Filing
09 Jun 2025	15-12G
27 May 2025	SCHEDULE 13D/A
23 May 2025	Form 4: AyurMaya Capital Management Company, Lp, Director and 1 other Returned 9,334,735 shares to the issuer
23 May 2025	SCHEDULE 13D/A
23 May 2025	SCHEDULE 13G/A
23 May 2025	Form 4: Kim Mina, Director Received 89,526 shares as a grant or award · Returned 770,833 shares to the issuer · Disposed of 1,833,915 Employee Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Cozadd Bruce C, Director Disposed of 298,835 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Murugan Amar, Chief Legal Officer Returned 121,587 shares to the issuer · Disposed of 525,000 Employee Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Seidenberg Beth C, Director Returned 9,850,729 shares to the issuer · Disposed of 115,401 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Mpofu Shephard, Chief Medical Officer Returned 121,789 shares to the issuer · Disposed of 590,304 Employee Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Gosebruch Henry O, Director Returned 50,000 shares to the issuer · Disposed of 247,608 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Machado Patrick, Director Returned 14,675 shares to the issuer · Disposed of 270,849 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Svoronos Dawn, Director Returned 15,000 shares to the issuer · Disposed of 270,851 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Becker Daniel J., Director Returned 2,999 shares to the issuer · Disposed of 115,401 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	Form 4: Tetrault Lynn A., Director Disposed of 133,635 Director Stock Option (right to buy) (Disposition to Issuer)
23 May 2025	SCHEDULE 13D/A
22 May 2025	EFFECT
22 May 2025	S-8 POS
22 May 2025	S-8 POS
22 May 2025	S-8 POS

Comments